|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period from to
|
|
Delaware
|
|
|
94-1672743
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
||
2200 Mission College Boulevard,
|
Santa Clara,
|
California
|
|
95054-1549
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common stock, $0.001 par value
|
INTC
|
Nasdaq Global Select Market
|
Large Accelerated Filer
|
Accelerated filer
|
Non-accelerated filer
|
Smaller reporting company
|
Emerging growth company
|
☑
|
¨
|
¨
|
☐
|
☐
|
|
|
|
Page
|
FORWARD-LOOKING STATEMENTS
|
|||
OUR PANDEMIC RESPONSE
|
|||
A QUARTER IN REVIEW
|
|||
CONSOLIDATED CONDENSED FINANCIAL STATEMENTS AND SUPPLEMENTAL DETAILS
|
|
||
|
Consolidated Condensed Statements of Income
|
||
|
Consolidated Condensed Statements of Comprehensive Income
|
||
|
Consolidated Condensed Balance Sheets
|
||
|
Consolidated Condensed Statements of Cash Flows
|
||
|
Consolidated Condensed Statements of Stockholders' Equity
|
||
|
Notes to Consolidated Condensed Financial Statements
|
||
|
Key Terms
|
||
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
||
|
Segment Trends and Results
|
||
|
Consolidated Results of Operations
|
||
|
Liquidity and Capital Resources
|
||
|
Contractual Obligations
|
||
|
Quantitative and Qualitative Disclosures about Market Risk
|
||
|
Non-GAAP Financial Measures
|
||
|
|
|
|
OTHER KEY INFORMATION
|
|
||
|
Risk Factors
|
||
|
Controls and Procedures
|
||
|
Issuer Purchases of Equity Securities
|
||
|
Exhibits
|
||
|
Form 10-Q Cross-Reference Index
|
1
|
Intel's definition is included in "Key Terms" within the Consolidated Condensed Financial Statements and Supplemental Details.
|
|
|
1
|
OUR PANDEMIC RESPONSE
|
OUR PANDEMIC RESPONSE
|
|
2
|
•
|
Where feasible and practicable, we increased inventory of raw materials as well as our supply of our finished goods coming out of China in early February. It is our practice to plan for scenarios where supply will be restricted or compromised in our supply chain for 30-60 days or more.
|
•
|
We activated backup planning to reroute and obtain charter flights if needed into and from China, securing capacity early. As the virus spread, we leveraged the successful methodology used in China for other parts of Asia and Europe.
|
•
|
We evaluated the end-to-end supply line needs for all products ramping this year, worked on securing supply lines and deployed our business continuity plans to mitigate potential risks.
|
•
|
We are giving COVID-19 scientists and researchers free access to our worldwide intellectual property portfolio. We will continue to invent—and protect—our intellectual property, but we offer it freely to those working to protect people from this pandemic.
|
•
|
We are teaming with Lenovo and BGI Genomics to accelerate the analysis of genomic characteristics of COVID-19. Our combined work will further advance the capabilities of BGI’s sequencing tools to help scientists investigate transmission patterns of the virus and create better diagnostic methods.
|
•
|
We are deploying Intel platform-based robots in hospitals to protect doctors and nurses by transporting medical supplies and surgical equipment to reduce human-to-human interactions.
|
•
|
We are working with Dyson and medical consultancy firm TTP to supply FPGAs for CoVent, a new ventilator specifically designed in response to the U.K. government’s request for help.
|
•
|
We are collaborating with Medtronic to add remote monitoring capabilities to their PB980 ventilator, which helps reduce exposure for healthcare providers treating COVID-19 patients.
|
•
|
We committed a $1 million donation to the International Red Cross to support global relief efforts for the COVID-19 pandemic.
|
•
|
We announced the Intel Foundation is providing $4 million to support COVID-19 relief efforts in communities where we have significant presence. The foundation also offered a special monetary matching opportunity for every regular full-time and part-time employee and U.S. Intel retiree up to a total of $2 million for relief efforts around major Intel sites.
|
•
|
We donated more than 1 million items of personal protective equipment—masks, gloves, and other gear—to healthcare workers that were sourced from our factory stock and emergency supplies.
|
•
|
We also joined the global XPRIZE Pandemic Alliance along with other companies to fuel collaboration on solutions through shared innovation to effectively address the immediate needs of the crisis.
|
OUR PANDEMIC RESPONSE
|
|
3
|
OUR PANDEMIC RESPONSE
|
|
4
|
A QUARTER IN REVIEW
|
REVENUE
|
|
OPERATING INCOME
|
|
DILUTED EPS
|
|
CASH FLOWS
|
■ PC-CENTRIC $B
■ DATA-CENTRIC $B
|
|
■ GAAP $B ■ NON-GAAP $B
|
|
■ GAAP ■ NON-GAAP
|
|
■ OPERATING CASH FLOW $B
■ FREE CASH FLOW $B
|
|
|
|
|
|
|
|
||||||||
$19.8B
|
|
|
|
$7.0B
|
|
$7.5B
|
|
$1.31
|
|
$1.45
|
|
$6.2B
|
|
$2.9B
|
GAAP
|
|
|
|
GAAP
|
|
non-GAAP2
|
|
GAAP
|
|
non-GAAP2
|
|
GAAP
|
|
non-GAAP2
|
Revenue up $3.8B or 23% from Q1 2019
|
|
Operating income up $2.9B or 69% from Q1 2019; Q1 2020 operating margin at 35%
|
|
Operating income up $3.0B or 67% from Q1 2019; Q1 2020 operating margin at 38%
|
|
Diluted EPS up $0.44 or 51% from Q1 2019
|
|
Diluted EPS up $0.56 or 63% from Q1 2019
|
|
Operating cash flow up $1.2B or 24% from Q1 2019
|
|
Free cash flow up $1.3B or 76% from Q1 2019
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Growth in most data-centric businesses and growth in the PC-centric business
|
|
Higher gross margin from increase in platform unit sales and platform ASP strength, lower period charges, NAND market recovery and improved NAND unit cost, partially offset by increase in platform unit cost
|
|
Higher platform volume, platform ASP strength, lower period charges, NAND market recovery and improved unit cost, and lower shares outstanding, partially offset by higher platform unit cost and higher tax
|
|
Higher net income offset by working capital changes driven by other assets and liabilities and accounts receivable
|
•
|
We introduced a broad, data-centric portfolio for 5G network infrastructure including the new Intel Atom® P5900, a 10nm SoC for wireless base stations; a next-generation structured ASIC for 5G network acceleration; and the launch of new 2nd Gen Intel® Xeon® Scalable processors.
|
•
|
We announced the 10th Gen Intel® Core™ H-series mobile processors, a new family of mobile processors aimed at gamers and creators everywhere, which deliver faster performance with up to 5.3GHz Turbo, eight cores, and 16 threads.
|
•
|
We experienced growth in most data-centric businesses. DCG grew across all segments and adjacencies continued to ramp. NSG grew with record revenue driven by NAND and Intel® Optane™ memory bit growth and higher ASP. Mobileye recognized record revenue with increasing ADAS adoption. IOTG declined on COVID-19 impact.
|
•
|
PC-centric growth was driven by notebook demand strength as consumers and businesses are relying on PCs for working and learning at home.
|
1
|
See "Key Terms" within Consolidated Condensed Financial Statements and Supplemental Details.
|
2
|
See "Non-GAAP Financial Measures" within MD&A.
|
A QUARTER IN REVIEW
|
|
5
|
CONSOLIDATED CONDENSED STATEMENTS OF INCOME
|
|
|
Three Months Ended
|
||||||
(In Millions, Except Per Share Amounts; Unaudited)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Net revenue
|
|
$
|
19,828
|
|
|
$
|
16,061
|
|
Cost of sales
|
|
7,812
|
|
|
6,972
|
|
||
Gross margin
|
|
12,016
|
|
|
9,089
|
|
||
Research and development
|
|
3,275
|
|
|
3,332
|
|
||
Marketing, general and administrative
|
|
1,541
|
|
|
1,583
|
|
||
Restructuring and other charges
|
|
162
|
|
|
—
|
|
||
Operating expenses
|
|
4,978
|
|
|
4,915
|
|
||
Operating income
|
|
7,038
|
|
|
4,174
|
|
||
Gains (losses) on equity investments, net
|
|
(111
|
)
|
|
434
|
|
||
Interest and other, net
|
|
(313
|
)
|
|
(61
|
)
|
||
Income before taxes
|
|
6,614
|
|
|
4,547
|
|
||
Provision for taxes
|
|
953
|
|
|
573
|
|
||
Net income
|
|
$
|
5,661
|
|
|
$
|
3,974
|
|
Earnings per share—basic
|
|
$
|
1.33
|
|
|
$
|
0.88
|
|
Earnings per share—diluted
|
|
$
|
1.31
|
|
|
$
|
0.87
|
|
Weighted average shares of common stock outstanding:
|
|
|
|
|
||||
Basic
|
|
4,266
|
|
|
4,492
|
|
||
Diluted
|
|
4,312
|
|
|
4,564
|
|
FINANCIAL STATEMENTS
|
Consolidated Condensed Statements of Income
|
6
|
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
|
|
|
Three Months Ended
|
||||||
(In Millions; Unaudited)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Net income
|
|
$
|
5,661
|
|
|
$
|
3,974
|
|
Changes in other comprehensive income, net of tax:
|
|
|
|
|
||||
Net unrealized holding gains (losses) on derivatives
|
|
(268
|
)
|
|
102
|
|
||
Actuarial valuation and other pension benefits (expenses), net
|
|
12
|
|
|
9
|
|
||
Translation adjustments and other
|
|
(5
|
)
|
|
50
|
|
||
Other comprehensive income (loss)
|
|
(261
|
)
|
|
161
|
|
||
Total comprehensive income
|
|
$
|
5,400
|
|
|
$
|
4,135
|
|
FINANCIAL STATEMENTS
|
Consolidated Condensed Statements of Comprehensive Income
|
7
|
CONSOLIDATED CONDENSED BALANCE SHEETS
|
(In Millions)
|
|
Mar 28,
2020 |
|
Dec 28,
2019 |
||||
|
|
(unaudited)
|
|
|
||||
Assets
|
|
|
|
|
||||
Current assets:
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
11,380
|
|
|
$
|
4,194
|
|
Short-term investments
|
|
1,296
|
|
|
1,082
|
|
||
Trading assets
|
|
8,127
|
|
|
7,847
|
|
||
Accounts receivable
|
|
8,455
|
|
|
7,659
|
|
||
Inventories
|
|
9,246
|
|
|
8,744
|
|
||
Other current assets
|
|
2,997
|
|
|
1,713
|
|
||
Total current assets
|
|
41,501
|
|
|
31,239
|
|
||
Property, plant and equipment, net of accumulated depreciation of $75,686 ($73,321 as of December 28, 2019)
|
|
56,770
|
|
|
55,386
|
|
||
Equity investments
|
|
3,880
|
|
|
3,967
|
|
||
Other long-term investments
|
|
2,943
|
|
|
3,276
|
|
||
Goodwill
|
|
26,276
|
|
|
26,276
|
|
||
Identified intangible assets, net
|
|
10,429
|
|
|
10,827
|
|
||
Other long-term assets
|
|
5,911
|
|
|
5,553
|
|
||
Total assets
|
|
$
|
147,710
|
|
|
$
|
136,524
|
|
|
|
|
|
|
||||
Liabilities, temporary equity, and stockholders’ equity
|
|
|
|
|
||||
Current liabilities:
|
|
|
|
|
||||
Short-term debt
|
|
$
|
3,464
|
|
|
$
|
3,693
|
|
Accounts payable
|
|
4,638
|
|
|
4,128
|
|
||
Accrued compensation and benefits
|
|
2,358
|
|
|
3,853
|
|
||
Other accrued liabilities
|
|
13,435
|
|
|
10,636
|
|
||
Total current liabilities
|
|
23,895
|
|
|
22,310
|
|
||
Debt
|
|
36,455
|
|
|
25,308
|
|
||
Contract liabilities
|
|
1,353
|
|
|
1,368
|
|
||
Income taxes payable, non-current
|
|
4,651
|
|
|
4,919
|
|
||
Deferred income taxes
|
|
2,027
|
|
|
2,044
|
|
||
Other long-term liabilities
|
|
2,975
|
|
|
2,916
|
|
||
Contingencies (Note 12)
|
|
|
|
|
||||
Temporary equity
|
|
—
|
|
|
155
|
|
||
Stockholders’ equity:
|
|
|
|
|
||||
Preferred stock
|
|
—
|
|
|
—
|
|
||
Common stock and capital in excess of par value, 4,234 issued and outstanding (4,290 issued and outstanding as of December 28, 2019)
|
|
25,251
|
|
|
25,261
|
|
||
Accumulated other comprehensive income (loss)
|
|
(1,541
|
)
|
|
(1,280
|
)
|
||
Retained earnings
|
|
52,644
|
|
|
53,523
|
|
||
Total stockholders’ equity
|
|
76,354
|
|
|
77,504
|
|
||
Total liabilities, temporary equity, and stockholders’ equity
|
|
$
|
147,710
|
|
|
$
|
136,524
|
|
FINANCIAL STATEMENTS
|
Consolidated Condensed Balance Sheets
|
8
|
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
|
|
|
Three Months Ended
|
||||||
(In Millions; Unaudited)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
|
|
|
|
|
||||
Cash and cash equivalents, beginning of period
|
|
$
|
4,194
|
|
|
$
|
3,019
|
|
Cash flows provided by (used for) operating activities:
|
|
|
|
|
||||
Net income
|
|
5,661
|
|
|
3,974
|
|
||
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
||||
Depreciation
|
|
2,623
|
|
|
2,229
|
|
||
Share-based compensation
|
|
449
|
|
|
389
|
|
||
Amortization of intangibles
|
|
427
|
|
|
396
|
|
||
(Gains) losses on equity investments, net
|
|
134
|
|
|
(274
|
)
|
||
Changes in assets and liabilities:
|
|
|
|
|
||||
Accounts receivable
|
|
(796
|
)
|
|
(235
|
)
|
||
Inventories
|
|
(548
|
)
|
|
(512
|
)
|
||
Accounts payable
|
|
117
|
|
|
196
|
|
||
Accrued compensation and benefits
|
|
(1,500
|
)
|
|
(1,620
|
)
|
||
Prepaid supply agreements
|
|
(87
|
)
|
|
(228
|
)
|
||
Income taxes
|
|
753
|
|
|
440
|
|
||
Other assets and liabilities
|
|
(1,075
|
)
|
|
204
|
|
||
Total adjustments
|
|
497
|
|
|
985
|
|
||
Net cash provided by operating activities
|
|
6,158
|
|
|
4,959
|
|
||
Cash flows provided by (used for) investing activities:
|
|
|
|
|
||||
Additions to property, plant and equipment
|
|
(3,268
|
)
|
|
(3,321
|
)
|
||
Purchases of available-for-sale debt investments
|
|
(513
|
)
|
|
(872
|
)
|
||
Maturities and sales of available-for-sale debt investments
|
|
625
|
|
|
948
|
|
||
Purchases of trading assets
|
|
(3,897
|
)
|
|
(1,869
|
)
|
||
Maturities and sales of trading assets
|
|
3,660
|
|
|
1,554
|
|
||
Sales of equity investments
|
|
20
|
|
|
1,077
|
|
||
Other investing
|
|
(363
|
)
|
|
(239
|
)
|
||
Net cash used for investing activities
|
|
(3,736
|
)
|
|
(2,722
|
)
|
||
Cash flows provided by (used for) financing activities:
|
|
|
|
|
||||
Increase (decrease) in short-term debt, net
|
|
—
|
|
|
1,682
|
|
||
Issuance of long-term debt, net of issuance costs
|
|
10,247
|
|
|
135
|
|
||
Repayment of debt and debt conversion
|
|
(1,075
|
)
|
|
(861
|
)
|
||
Proceeds from sales of common stock through employee equity incentive plans
|
|
503
|
|
|
290
|
|
||
Repurchase of common stock
|
|
(4,229
|
)
|
|
(2,530
|
)
|
||
Payment of dividends to stockholders
|
|
(1,408
|
)
|
|
(1,414
|
)
|
||
Other financing
|
|
726
|
|
|
596
|
|
||
Net cash provided by (used for) financing activities
|
|
4,764
|
|
|
(2,102
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
|
7,186
|
|
|
135
|
|
||
Cash and cash equivalents, end of period
|
|
$
|
11,380
|
|
|
$
|
3,154
|
|
|
|
|
|
|
||||
Supplemental disclosures of noncash investing activities and cash flow information:
|
|
|
|
|
||||
Acquisition of property, plant, and equipment included in accounts payable and accrued liabilities
|
|
$
|
2,294
|
|
|
$
|
2,259
|
|
Cash paid during the period for:
|
|
|
|
|
||||
Interest, net of capitalized interest
|
|
$
|
67
|
|
|
$
|
109
|
|
Income taxes, net of refunds
|
|
$
|
211
|
|
|
$
|
125
|
|
FINANCIAL STATEMENTS
|
Consolidated Condensed Statements of Cash Flows
|
9
|
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY
|
|
|
Common Stock and Capital in Excess of Par Value
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Total
|
|||||||||||
(In Millions, Except Per Share Amounts; Unaudited)
|
|
Shares
|
|
Amount
|
|
|
|
||||||||||||
Three Months Ended
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Balance as of December 29, 2019
|
|
4,290
|
|
|
$
|
25,261
|
|
|
$
|
(1,280
|
)
|
|
$
|
53,523
|
|
|
$
|
77,504
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,661
|
|
|
5,661
|
|
||||
Other comprehensive income (loss)
|
|
—
|
|
|
—
|
|
|
(261
|
)
|
|
—
|
|
|
(261
|
)
|
||||
Employee equity incentive plans and other
|
|
17
|
|
|
620
|
|
|
—
|
|
|
—
|
|
|
620
|
|
||||
Share-based compensation
|
|
—
|
|
|
449
|
|
|
—
|
|
|
—
|
|
|
449
|
|
||||
Temporary equity reduction
|
|
—
|
|
|
155
|
|
|
—
|
|
|
—
|
|
|
155
|
|
||||
Convertible debt
|
|
—
|
|
|
(750
|
)
|
|
—
|
|
|
—
|
|
|
(750
|
)
|
||||
Repurchase of common stock
|
|
(71
|
)
|
|
(420
|
)
|
|
—
|
|
|
(3,689
|
)
|
|
(4,109
|
)
|
||||
Restricted stock unit withholdings
|
|
(2
|
)
|
|
(64
|
)
|
|
—
|
|
|
(32
|
)
|
|
(96
|
)
|
||||
Cash dividends declared ($0.66 per share)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,819
|
)
|
|
(2,819
|
)
|
||||
Balance as of March 28, 2020
|
|
4,234
|
|
|
$
|
25,251
|
|
|
$
|
(1,541
|
)
|
|
$
|
52,644
|
|
|
$
|
76,354
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Balance as of December 28, 2018
|
|
4,516
|
|
|
$
|
25,365
|
|
|
$
|
(974
|
)
|
|
$
|
50,172
|
|
|
$
|
74,563
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,974
|
|
|
3,974
|
|
||||
Other comprehensive income (loss)
|
|
—
|
|
|
—
|
|
|
161
|
|
|
—
|
|
|
161
|
|
||||
Employee equity incentive plans and other
|
|
11
|
|
|
372
|
|
|
—
|
|
|
—
|
|
|
372
|
|
||||
Share-based compensation
|
|
—
|
|
|
389
|
|
|
—
|
|
|
—
|
|
|
389
|
|
||||
Temporary equity reduction
|
|
—
|
|
|
145
|
|
|
—
|
|
|
—
|
|
|
145
|
|
||||
Convertible debt
|
|
—
|
|
|
(592
|
)
|
|
—
|
|
|
—
|
|
|
(592
|
)
|
||||
Repurchase of common stock
|
|
(49
|
)
|
|
(278
|
)
|
|
—
|
|
|
(2,172
|
)
|
|
(2,450
|
)
|
||||
Restricted stock unit withholdings
|
|
(1
|
)
|
|
(55
|
)
|
|
—
|
|
|
(17
|
)
|
|
(72
|
)
|
||||
Cash dividends declared ($0.63 per share)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,829
|
)
|
|
(2,829
|
)
|
||||
Balance as of March 30, 2019
|
|
4,477
|
|
|
$
|
25,346
|
|
|
$
|
(813
|
)
|
|
$
|
49,128
|
|
|
$
|
73,661
|
|
FINANCIAL STATEMENTS
|
Consolidated Condensed Statements of Stockholders' Equity
|
10
|
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
|
NOTE 1 :
|
BASIS OF PRESENTATION
|
NOTE 2 :
|
OPERATING SEGMENTS
|
•
|
DCG
|
•
|
IOTG
|
•
|
Mobileye
|
•
|
NSG
|
•
|
PSG
|
•
|
CCG
|
•
|
results of operations from non-reportable segments not otherwise presented;
|
•
|
historical results of operations from divested businesses;
|
•
|
results of operations of start-up businesses that support our initiatives, including our foundry business;
|
•
|
amounts included within restructuring and other charges;
|
•
|
a portion of employee benefits, compensation, and other expenses not allocated to the operating segments; and
|
•
|
acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill.
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
11
|
|
|
Three Months Ended
|
||||||
(In Millions)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Net revenue:
|
|
|
|
|
||||
Data Center Group
|
|
|
|
|
||||
Platform
|
|
$
|
6,427
|
|
|
$
|
4,482
|
|
Adjacent
|
|
566
|
|
|
420
|
|
||
|
|
6,993
|
|
|
4,902
|
|
||
Internet of Things
|
|
|
|
|
||||
IOTG
|
|
883
|
|
|
910
|
|
||
Mobileye
|
|
254
|
|
|
209
|
|
||
|
|
1,137
|
|
|
1,119
|
|
||
|
|
|
|
|
||||
Non-Volatile Memory Solutions Group
|
|
1,338
|
|
|
915
|
|
||
Programmable Solutions Group
|
|
519
|
|
|
486
|
|
||
Client Computing Group
|
|
|
|
|
||||
Platform
|
|
8,712
|
|
|
7,824
|
|
||
Adjacent
|
|
1,063
|
|
|
762
|
|
||
|
|
9,775
|
|
|
8,586
|
|
||
|
|
|
|
|
||||
All other
|
|
66
|
|
|
53
|
|
||
Total net revenue
|
|
$
|
19,828
|
|
|
$
|
16,061
|
|
|
|
|
|
|
||||
Operating income (loss):
|
|
|
|
|
||||
Data Center Group
|
|
$
|
3,492
|
|
|
$
|
1,841
|
|
|
|
|
|
|
||||
Internet of Things
|
|
|
|
|
||||
IOTG
|
|
243
|
|
|
251
|
|
||
Mobileye
|
|
88
|
|
|
68
|
|
||
|
|
331
|
|
|
319
|
|
||
|
|
|
|
|
||||
Non-Volatile Memory Solutions Group
|
|
(66
|
)
|
|
(297
|
)
|
||
Programmable Solutions Group
|
|
97
|
|
|
89
|
|
||
Client Computing Group
|
|
4,225
|
|
|
3,072
|
|
||
All other
|
|
(1,041
|
)
|
|
(850
|
)
|
||
Total operating income
|
|
$
|
7,038
|
|
|
$
|
4,174
|
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
12
|
|
|
Three Months Ended
|
||||||
(In Millions)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Platform revenue
|
|
|
|
|
||||
DCG platform
|
|
$
|
6,427
|
|
|
$
|
4,482
|
|
IOTG platform
|
|
795
|
|
|
825
|
|
||
CCG Desktop platform
|
|
2,840
|
|
|
2,886
|
|
||
CCG Notebook platform
|
|
5,857
|
|
|
4,926
|
|
||
CCG other platform1
|
|
15
|
|
|
12
|
|
||
|
|
15,934
|
|
|
13,131
|
|
||
|
|
|
|
|
||||
Adjacent revenue2
|
|
3,894
|
|
|
2,930
|
|
||
Total revenue
|
|
$
|
19,828
|
|
|
$
|
16,061
|
|
1
|
Includes our tablet and service provider revenue.
|
2
|
Includes all of our non-platform products for DCG, IOTG, and CCG such as modem, Ethernet, and silicon photonics, as well as Mobileye, NSG, and PSG products.
|
NOTE 3 :
|
EARNINGS PER SHARE
|
|
|
Three Months Ended
|
||||||
(In Millions, Except Per Share Amounts)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Net income available to common stockholders
|
|
$
|
5,661
|
|
|
$
|
3,974
|
|
Weighted average shares of common stock outstanding—basic
|
|
4,266
|
|
|
4,492
|
|
||
Dilutive effect of employee equity incentive plans
|
|
46
|
|
|
53
|
|
||
Dilutive effect of convertible debt
|
|
—
|
|
|
19
|
|
||
Weighted average shares of common stock outstanding—diluted
|
|
4,312
|
|
|
4,564
|
|
||
Earnings per share—basic
|
|
$
|
1.33
|
|
|
$
|
0.88
|
|
Earnings per share—diluted
|
|
$
|
1.31
|
|
|
$
|
0.87
|
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
13
|
NOTE 4 :
|
CONTRACT LIABILITIES
|
(In Millions)
|
|
Mar 28,
2020 |
|
Dec 28,
2019 |
||||
Prepaid supply agreements
|
|
$
|
1,718
|
|
|
$
|
1,805
|
|
Other
|
|
271
|
|
|
236
|
|
||
Total contract liabilities
|
|
$
|
1,989
|
|
|
$
|
2,041
|
|
(In Millions)
|
|
|
||
Prepaid supply agreements balance as of December 28, 2019
|
|
$
|
1,805
|
|
Prepayments utilized
|
|
(87
|
)
|
|
Prepaid supply agreements balance as of March 28, 2020
|
|
$
|
1,718
|
|
NOTE 5 :
|
OTHER FINANCIAL STATEMENT DETAILS
|
(In Millions)
|
|
Mar 28,
2020 |
|
Dec 28,
2019 |
||||
Raw materials
|
|
$
|
877
|
|
|
$
|
840
|
|
Work in process
|
|
6,654
|
|
|
6,225
|
|
||
Finished goods
|
|
1,715
|
|
|
1,679
|
|
||
Total inventories
|
|
$
|
9,246
|
|
|
$
|
8,744
|
|
|
|
Three Months Ended
|
||||||
(In Millions)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Interest income
|
|
$
|
93
|
|
|
$
|
135
|
|
Interest expense
|
|
(135
|
)
|
|
(138
|
)
|
||
Other, net
|
|
(271
|
)
|
|
(58
|
)
|
||
Total interest and other, net
|
|
$
|
(313
|
)
|
|
$
|
(61
|
)
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
14
|
NOTE 6 :
|
RESTRUCTURING AND OTHER CHARGES
|
|
|
Three Months Ended
|
||
(In Millions)
|
|
Mar 28,
2020 |
||
Employee severance and benefit arrangements
|
|
$
|
105
|
|
Asset impairment and other charges
|
|
57
|
|
|
Total restructuring and other charges
|
|
$
|
162
|
|
NOTE 7 :
|
INVESTMENTS
|
|
|
March 28, 2020
|
|
December 28, 2019
|
||||||||||||||||||||||||||||
(In Millions)
|
|
Adjusted Cost
|
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Fair Value
|
|
Adjusted Cost
|
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Fair Value
|
||||||||||||||||
Corporate debt
|
|
$
|
3,656
|
|
|
$
|
46
|
|
|
$
|
(9
|
)
|
|
$
|
3,693
|
|
|
$
|
2,914
|
|
|
$
|
44
|
|
|
$
|
—
|
|
|
$
|
2,958
|
|
Financial institution
instruments |
|
9,482
|
|
|
12
|
|
|
(2
|
)
|
|
9,492
|
|
|
3,007
|
|
|
15
|
|
|
(1
|
)
|
|
3,021
|
|
||||||||
Government debt
|
|
748
|
|
|
11
|
|
|
(1
|
)
|
|
758
|
|
|
560
|
|
|
4
|
|
|
—
|
|
|
564
|
|
||||||||
Total available-for-sale debt investments
|
|
$
|
13,886
|
|
|
$
|
69
|
|
|
$
|
(12
|
)
|
|
$
|
13,943
|
|
|
$
|
6,481
|
|
|
$
|
63
|
|
|
$
|
(1
|
)
|
|
$
|
6,543
|
|
(In Millions)
|
|
Fair Value
|
||
Due in 1 year or less
|
|
$
|
3,443
|
|
Due in 1–2 years
|
|
1,589
|
|
|
Due in 2–5 years
|
|
1,354
|
|
|
Due after 5 years
|
|
—
|
|
|
Instruments not due at a single maturity date
|
|
7,557
|
|
|
Total
|
|
$
|
13,943
|
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
15
|
(In Millions)
|
|
Mar 28,
2020 |
|
Dec 28,
2019 |
||||
Marketable equity securities
|
|
$
|
330
|
|
|
$
|
450
|
|
Non-marketable equity securities
|
|
3,522
|
|
|
3,480
|
|
||
Equity method investments
|
|
28
|
|
|
37
|
|
||
Total
|
|
$
|
3,880
|
|
|
$
|
3,967
|
|
|
|
Three Months Ended
|
||||||
(In Millions)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Ongoing mark-to-market adjustments on marketable equity securities
|
|
$
|
(103
|
)
|
|
$
|
253
|
|
Observable price adjustments on non-marketable equity securities
|
|
79
|
|
|
8
|
|
||
Impairment charges
|
|
(143
|
)
|
|
(23
|
)
|
||
Sale of equity investments and other¹
|
|
56
|
|
|
196
|
|
||
Total gains (losses) on equity investments, net
|
|
$
|
(111
|
)
|
|
$
|
434
|
|
|
|
Three Months Ended
|
||||||
(In Millions)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Net gains (losses) recognized during the period on equity securities
|
|
$
|
(140
|
)
|
|
$
|
263
|
|
Less: Net (gains) losses recognized during the period on equity securities sold during the period
|
|
(7
|
)
|
|
(190
|
)
|
||
Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date
|
|
$
|
(147
|
)
|
|
$
|
73
|
|
NOTE 8 :
|
BORROWINGS
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
16
|
|
|
Mar 28,
2020 |
|
Dec 28,
2019 |
|||||||
(In Millions)
|
|
Effective Interest Rate
|
|
Amount
|
|
Amount
|
|||||
Floating-rate senior notes:
|
|
|
|
|
|
|
|||||
Three-month LIBOR plus 0.08%, due May 2020
|
|
1.93
|
%
|
|
$
|
700
|
|
|
$
|
700
|
|
Three-month LIBOR plus 0.35%, due May 2022
|
|
2.19
|
%
|
|
800
|
|
|
800
|
|
||
Fixed-rate senior notes:
|
|
|
|
|
|
|
|||||
1.85%, due May 2020
|
|
1.88
|
%
|
|
1,000
|
|
|
1,000
|
|
||
2.45%, due July 2020
|
|
2.47
|
%
|
|
1,750
|
|
|
1,750
|
|
||
1.70%, due May 2021
|
|
1.77
|
%
|
|
500
|
|
|
500
|
|
||
3.30%, due October 2021
|
|
2.96
|
%
|
|
2,000
|
|
|
2,000
|
|
||
2.35%, due May 2022
|
|
1.95
|
%
|
|
750
|
|
|
750
|
|
||
3.10%, due July 2022
|
|
2.68
|
%
|
|
1,000
|
|
|
1,000
|
|
||
4.00%, due December 2022¹
|
|
3.61
|
%
|
|
325
|
|
|
382
|
|
||
2.70%, due December 2022
|
|
2.27
|
%
|
|
1,500
|
|
|
1,500
|
|
||
4.10%, due November 2023
|
|
3.20
|
%
|
|
400
|
|
|
400
|
|
||
2.88%, due May 2024
|
|
2.30
|
%
|
|
1,250
|
|
|
1,250
|
|
||
2.70%, due June 2024
|
|
2.12
|
%
|
|
600
|
|
|
600
|
|
||
3.40%, due March 2025
|
|
3.46
|
%
|
|
1,500
|
|
|
—
|
|
||
3.70%, due July 2025
|
|
3.81
|
%
|
|
2,250
|
|
|
2,250
|
|
||
2.60%, due May 2026
|
|
2.28
|
%
|
|
1,000
|
|
|
1,000
|
|
||
3.75%, due March 2027
|
|
3.80
|
%
|
|
1,000
|
|
|
—
|
|
||
3.15%, due May 2027
|
|
2.84
|
%
|
|
1,000
|
|
|
1,000
|
|
||
2.45%, due November 2029
|
|
2.45
|
%
|
|
2,000
|
|
|
1,250
|
|
||
3.90%, due March 2030
|
|
3.94
|
%
|
|
1,500
|
|
|
—
|
|
||
4.00%, due December 2032
|
|
2.82
|
%
|
|
750
|
|
|
750
|
|
||
4.60%, due March 2040
|
|
4.63
|
%
|
|
750
|
|
|
—
|
|
||
4.80%, due October 2041
|
|
3.75
|
%
|
|
802
|
|
|
802
|
|
||
4.25%, due December 2042
|
|
3.00
|
%
|
|
567
|
|
|
567
|
|
||
4.90%, due July 2045
|
|
3.78
|
%
|
|
772
|
|
|
772
|
|
||
4.10%, due May 2046
|
|
3.04
|
%
|
|
1,250
|
|
|
1,250
|
|
||
4.10%, due May 2047
|
|
3.00
|
%
|
|
1,000
|
|
|
1,000
|
|
||
4.10%, due August 2047
|
|
2.58
|
%
|
|
640
|
|
|
640
|
|
||
3.73%, due December 2047
|
|
3.30
|
%
|
|
1,967
|
|
|
1,967
|
|
||
3.25%, due November 2049
|
|
3.22
|
%
|
|
2,000
|
|
|
1,500
|
|
||
4.75%, due March 2050
|
|
4.77
|
%
|
|
2,250
|
|
|
—
|
|
||
3.10%, due February 2060
|
|
3.12
|
%
|
|
1,000
|
|
|
—
|
|
||
4.95%, due March 2060
|
|
5.02
|
%
|
|
1,000
|
|
|
—
|
|
||
Oregon and Arizona bonds:
|
|
|
|
|
|
|
|
||||
2.40%-2.70%, due December 2035 - 2040
|
|
2.49
|
%
|
|
423
|
|
|
423
|
|
||
5.00%, due March 2049
|
|
2.11
|
%
|
|
138
|
|
|
138
|
|
||
5.00%, due June 2049
|
|
2.13
|
%
|
|
438
|
|
|
438
|
|
||
Junior Subordinated Convertible Debentures:
|
|
|
|
|
|
|
|||||
3.25%, due August 2039
|
|
—
|
|
|
—
|
|
|
372
|
|
||
Total Senior Notes and Other Borrowings
|
|
|
|
38,572
|
|
|
28,751
|
|
|||
Unamortized Premium/Discount and Issuance Costs
|
|
|
|
(379
|
)
|
|
(529
|
)
|
|||
Hedge Accounting Fair Value Adjustments
|
|
|
|
1,726
|
|
|
781
|
|
|||
Long-term debt
|
|
|
|
39,919
|
|
|
29,003
|
|
|||
Current portion of long-term debt
|
|
|
|
(3,464
|
)
|
|
(3,695
|
)
|
|||
Total long-term debt
|
|
|
|
$
|
36,455
|
|
|
$
|
25,308
|
|
1
|
To manage foreign currency risk associated with the Australian-dollar-denominated notes issued in 2015, we entered into currency interest rate swaps with an aggregate notional amount of $396 million, which effectively converted these notes to U.S.-dollar-denominated notes. For further discussion on our currency interest rate swaps, see "Note 11: Derivative Financial Instruments."
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
17
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
18
|
NOTE 9 :
|
FAIR VALUE
|
|
|
March 28, 2020
|
|
December 28, 2019
|
||||||||||||||||||||||||||||
|
|
Fair Value Measured and
Recorded at Reporting Date Using
|
|
|
Fair Value Measured and
Recorded at Reporting Date Using
|
|
||||||||||||||||||||||||||
(In Millions)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||||||||||
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Corporate debt
|
|
$
|
—
|
|
|
$
|
1,348
|
|
|
$
|
—
|
|
|
$
|
1,348
|
|
|
$
|
—
|
|
|
$
|
713
|
|
|
$
|
—
|
|
|
$
|
713
|
|
Financial institution instruments¹
|
|
7,557
|
|
|
600
|
|
|
—
|
|
|
8,157
|
|
|
1,064
|
|
|
408
|
|
|
—
|
|
|
1,472
|
|
||||||||
Government debt²
|
|
—
|
|
|
199
|
|
|
—
|
|
|
199
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Reverse repurchase agreements
|
|
—
|
|
|
1,150
|
|
|
—
|
|
|
1,150
|
|
|
—
|
|
|
1,500
|
|
|
—
|
|
|
1,500
|
|
||||||||
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Corporate debt
|
|
—
|
|
|
493
|
|
|
—
|
|
|
493
|
|
|
—
|
|
|
347
|
|
|
—
|
|
|
347
|
|
||||||||
Financial institution instruments¹
|
|
—
|
|
|
803
|
|
|
—
|
|
|
803
|
|
|
—
|
|
|
724
|
|
|
—
|
|
|
724
|
|
||||||||
Government debt²
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|
—
|
|
|
11
|
|
||||||||
Trading assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Corporate debt
|
|
—
|
|
|
2,850
|
|
|
—
|
|
|
2,850
|
|
|
—
|
|
|
2,848
|
|
|
—
|
|
|
2,848
|
|
||||||||
Financial institution instruments¹
|
|
78
|
|
|
2,020
|
|
|
—
|
|
|
2,098
|
|
|
87
|
|
|
1,578
|
|
|
—
|
|
|
1,665
|
|
||||||||
Government debt²
|
|
—
|
|
|
3,179
|
|
|
—
|
|
|
3,179
|
|
|
—
|
|
|
3,334
|
|
|
—
|
|
|
3,334
|
|
||||||||
Other current assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Derivative assets
|
|
5
|
|
|
372
|
|
|
—
|
|
|
377
|
|
|
50
|
|
|
230
|
|
|
—
|
|
|
280
|
|
||||||||
Loans receivable³
|
|
—
|
|
|
339
|
|
|
—
|
|
|
339
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Marketable equity securities
|
|
330
|
|
|
—
|
|
|
—
|
|
|
330
|
|
|
450
|
|
|
—
|
|
|
—
|
|
|
450
|
|
||||||||
Other long-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Corporate debt
|
|
—
|
|
|
1,852
|
|
|
—
|
|
|
1,852
|
|
|
—
|
|
|
1,898
|
|
|
—
|
|
|
1,898
|
|
||||||||
Financial institution instruments¹
|
|
—
|
|
|
532
|
|
|
—
|
|
|
532
|
|
|
—
|
|
|
825
|
|
|
—
|
|
|
825
|
|
||||||||
Government debt²
|
|
—
|
|
|
559
|
|
|
—
|
|
|
559
|
|
|
—
|
|
|
553
|
|
|
—
|
|
|
553
|
|
||||||||
Other long-term assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Derivative assets
|
|
—
|
|
|
1,604
|
|
|
35
|
|
|
1,639
|
|
|
—
|
|
|
690
|
|
|
16
|
|
|
706
|
|
||||||||
Loans receivable³
|
|
—
|
|
|
203
|
|
|
—
|
|
|
203
|
|
|
—
|
|
|
554
|
|
|
—
|
|
|
554
|
|
||||||||
Total assets measured and recorded at fair value
|
|
$
|
7,970
|
|
|
$
|
18,103
|
|
|
$
|
35
|
|
|
$
|
26,108
|
|
|
$
|
1,651
|
|
|
$
|
16,213
|
|
|
$
|
16
|
|
|
$
|
17,880
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Other accrued liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Derivative liabilities
|
|
$
|
190
|
|
|
$
|
614
|
|
|
$
|
—
|
|
|
$
|
804
|
|
|
$
|
3
|
|
|
$
|
287
|
|
|
$
|
—
|
|
|
$
|
290
|
|
Other long-term liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Derivative liabilities
|
|
—
|
|
|
106
|
|
|
—
|
|
|
106
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
||||||||
Total liabilities measured and recorded at fair value
|
|
$
|
190
|
|
|
$
|
720
|
|
|
$
|
—
|
|
|
$
|
910
|
|
|
$
|
3
|
|
|
$
|
300
|
|
|
$
|
—
|
|
|
$
|
303
|
|
1
|
Level 1 investments consist of money market funds. Level 2 investments consist primarily of commercial paper, certificates of deposit, time deposits, and notes and bonds issued by financial institutions.
|
2
|
Level 2 investments consist primarily of U.S. agency notes and non-U.S. government debt.
|
3
|
The fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency.
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
19
|
NOTE 10 :
|
OTHER COMPREHENSIVE INCOME (LOSS)
|
(In Millions)
|
|
Unrealized Holding Gains (Losses) on Derivatives
|
|
Actuarial Valuation and Other Pension Expenses
|
|
Translation Adjustments and Other
|
|
Total
|
||||||||
Balance as of December 29, 2019
|
|
$
|
54
|
|
|
$
|
(1,382
|
)
|
|
$
|
48
|
|
|
$
|
(1,280
|
)
|
Other comprehensive income (loss) before reclassifications
|
|
(373
|
)
|
|
3
|
|
|
(6
|
)
|
|
(376
|
)
|
||||
Amounts reclassified out of accumulated other comprehensive income (loss)
|
|
68
|
|
|
14
|
|
|
—
|
|
|
82
|
|
||||
Tax effects
|
|
37
|
|
|
(5
|
)
|
|
1
|
|
|
33
|
|
||||
Other comprehensive income (loss)
|
|
(268
|
)
|
|
12
|
|
|
(5
|
)
|
|
(261
|
)
|
||||
Balance as of March 28, 2020
|
|
$
|
(214
|
)
|
|
$
|
(1,370
|
)
|
|
$
|
43
|
|
|
$
|
(1,541
|
)
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
20
|
NOTE 11 :
|
DERIVATIVE FINANCIAL INSTRUMENTS
|
(In Millions)
|
|
Mar 28,
2020 |
|
Dec 28,
2019 |
||||
Foreign currency contracts
|
|
$
|
27,039
|
|
|
$
|
23,981
|
|
Interest rate contracts
|
|
13,859
|
|
|
14,302
|
|
||
Other
|
|
1,726
|
|
|
1,753
|
|
||
Total
|
|
$
|
42,624
|
|
|
$
|
40,036
|
|
|
|
March 28, 2020
|
|
December 28, 2019
|
||||||||||||
(In Millions)
|
|
Assets1
|
|
Liabilities2
|
|
Assets1
|
|
Liabilities2
|
||||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
|
||||||||
Foreign currency contracts3
|
|
$
|
10
|
|
|
$
|
465
|
|
|
$
|
56
|
|
|
$
|
159
|
|
Interest rate contracts
|
|
1,635
|
|
|
—
|
|
|
690
|
|
|
9
|
|
||||
Total derivatives designated as hedging instruments
|
|
1,645
|
|
|
465
|
|
|
746
|
|
|
168
|
|
||||
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
||||||||
Foreign currency contracts3
|
|
362
|
|
|
135
|
|
|
179
|
|
|
78
|
|
||||
Interest rate contracts
|
|
4
|
|
|
120
|
|
|
11
|
|
|
54
|
|
||||
Equity contracts
|
|
5
|
|
|
190
|
|
|
50
|
|
|
3
|
|
||||
Total derivatives not designated as hedging instruments
|
|
371
|
|
|
445
|
|
|
240
|
|
|
135
|
|
||||
Total derivatives
|
|
$
|
2,016
|
|
|
$
|
910
|
|
|
$
|
986
|
|
|
$
|
303
|
|
1
|
Derivative assets are recorded as other assets, current and non-current.
|
2
|
Derivative liabilities are recorded as other liabilities, current and non-current.
|
3
|
The majority of these instruments mature within 12 months.
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
21
|
|
|
March 28, 2020
|
||||||||||||||||||||||
|
|
|
|
|
|
|
|
Gross Amounts Not Offset in the Balance Sheet
|
|
|
||||||||||||||
(In Millions)
|
|
Gross Amounts Recognized
|
|
Gross Amounts Offset in the Balance Sheet
|
|
Net Amounts Presented in the Balance Sheet
|
|
Financial Instruments
|
|
Cash and Non-Cash Collateral Received or Pledged
|
|
Net Amount
|
||||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative assets subject to master netting arrangements
|
|
$
|
2,005
|
|
|
$
|
—
|
|
|
$
|
2,005
|
|
|
$
|
(457
|
)
|
|
$
|
(1,513
|
)
|
|
$
|
35
|
|
Reverse repurchase agreements
|
|
1,500
|
|
|
—
|
|
|
1,500
|
|
|
—
|
|
|
(1,418
|
)
|
|
82
|
|
||||||
Total assets
|
|
$
|
3,505
|
|
|
$
|
—
|
|
|
$
|
3,505
|
|
|
$
|
(457
|
)
|
|
$
|
(2,931
|
)
|
|
$
|
117
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative liabilities subject to master netting arrangements
|
|
$
|
865
|
|
|
$
|
—
|
|
|
$
|
865
|
|
|
$
|
(457
|
)
|
|
$
|
(221
|
)
|
|
$
|
187
|
|
Total liabilities
|
|
$
|
865
|
|
|
$
|
—
|
|
|
$
|
865
|
|
|
$
|
(457
|
)
|
|
$
|
(221
|
)
|
|
$
|
187
|
|
|
|
December 28, 2019
|
||||||||||||||||||||||
|
|
|
|
|
|
|
|
Gross Amounts Not Offset in the Balance Sheet
|
|
|
||||||||||||||
(In Millions)
|
|
Gross Amounts Recognized
|
|
Gross Amounts Offset in the Balance Sheet
|
|
Net Amounts Presented in the Balance Sheet
|
|
Financial Instruments
|
|
Cash and Non-Cash Collateral Received or Pledged
|
|
Net Amount
|
||||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative assets subject to master netting arrangements
|
|
$
|
974
|
|
|
$
|
—
|
|
|
$
|
974
|
|
|
$
|
(144
|
)
|
|
$
|
(808
|
)
|
|
$
|
22
|
|
Reverse repurchase agreements
|
|
1,850
|
|
|
—
|
|
|
1,850
|
|
|
—
|
|
|
(1,850
|
)
|
|
—
|
|
||||||
Total assets
|
|
$
|
2,824
|
|
|
$
|
—
|
|
|
$
|
2,824
|
|
|
$
|
(144
|
)
|
|
$
|
(2,658
|
)
|
|
$
|
22
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Derivative liabilities subject to master netting arrangements
|
|
$
|
262
|
|
|
$
|
—
|
|
|
$
|
262
|
|
|
$
|
(144
|
)
|
|
$
|
(72
|
)
|
|
$
|
46
|
|
Total liabilities
|
|
$
|
262
|
|
|
$
|
—
|
|
|
$
|
262
|
|
|
$
|
(144
|
)
|
|
$
|
(72
|
)
|
|
$
|
46
|
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
22
|
|
|
Gains (Losses) Recognized in Consolidated Condensed Statements of Income on Derivatives
|
||||||
Three Months Ended
(In Millions)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Interest rate contracts
|
|
$
|
954
|
|
|
$
|
485
|
|
Hedged items
|
|
(954
|
)
|
|
(485
|
)
|
||
Total
|
|
$
|
—
|
|
|
$
|
—
|
|
Line Item in the Consolidated Condensed Balance Sheet in Which the Hedged Item is Included
|
|
Carrying Amount of the Hedged Item Asset/(Liabilities)
|
|
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities)
|
||||||||||||
(In Millions)
|
|
Mar 28,
2020 |
|
Dec 28,
2019 |
|
Mar 28,
2020 |
|
Dec 28,
2019 |
||||||||
Long-term debt
|
|
$
|
(13,632
|
)
|
|
$
|
(12,678
|
)
|
|
$
|
(1,635
|
)
|
|
$
|
(681
|
)
|
|
|
|
|
Three Months Ended
|
||||||
(In Millions)
|
|
Location of Gains (Losses)
Recognized in Income on Derivatives
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Foreign currency contracts
|
|
Interest and other, net
|
|
$
|
154
|
|
|
$
|
57
|
|
Interest rate contracts
|
|
Interest and other, net
|
|
(77
|
)
|
|
(14
|
)
|
||
Other
|
|
Various
|
|
(268
|
)
|
|
146
|
|
||
Total
|
|
|
|
$
|
(191
|
)
|
|
$
|
189
|
|
NOTE 12 :
|
CONTINGENCIES
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
23
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
24
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
25
|
KEY TERMS
|
TERM
|
|
DEFINITION
|
|
|
|
2009 Debentures
|
|
3.25% junior subordinated convertible debentures due 2039
|
5G
|
|
The next-generation mobile network, which is expected to bring dramatic improvements in network speeds and latency, and which we view as a transformative technology and opportunity for many industries
|
ADAS
|
|
Advanced driver-assistance systems
|
Adjacent products
|
|
All of our non-platform products for CCG, DCG, and IOTG, such as modem, Ethernet and silicon photonics, as well as Mobileye, Non-Volatile Memory Solutions Group (NSG), and Programmable Solutions Group (PSG) products. Combined with our platform products, adjacent products form comprehensive platform solutions to meet customer needs
|
ASIC
|
|
Application-specific integrated circuit
|
ASP
|
|
Average Selling Price
|
CODM
|
|
Chief operating decision maker
|
COVID-19
|
|
The infectious disease caused by the most recently discovered coronavirus (aka coronavirus 2 or SARS-CoV-2), which was declared a global pandemic by the World Health Organization
|
CPU
|
|
Processor or central processing unit
|
Data-centric businesses
|
|
Includes our Data Center Group (DCG), Internet of Things Group (IOTG), Mobileye, Non-Volatile Memory Solutions Group (NSG), Programmable Solutions Group (PSG), and all other businesses
|
EC
|
|
European Commission
|
Edge
|
|
Allocated resources that move, store, and process data closer to the source or point of service delivery
|
Form 10-K
|
|
Annual Report on Form 10-K
|
Form 10-Q
|
|
Quarterly Report on Form 10-Q
|
FPGA
|
|
Field-programmable gate array
|
IMFT
|
|
IM Flash Technologies, LLC
|
Internet of Things
|
|
Refers to the Internet of Things market in which we sell our IOTG and Mobileye products
|
IP
|
|
Intellectual property
|
McAfee
|
|
Business, post divestiture of Intel Security Group in Q2 2017, which we retained an interest in as part of our investment strategy
|
MD&A
|
|
Management's Discussion & Analysis
|
MG&A
|
|
Marketing, general and administrative
|
NAND
|
|
NAND flash memory
|
nm
|
|
Nanometer
|
OEM
|
|
Original equipment manufacturer
|
PC-centric business
|
|
Our Client Computing Group (CCG) business, including both platform and adjacent products
|
Platform products
|
|
A microprocessor (CPU) and chipset, a stand-alone SoC, or a multichip package, based on Intel® architecture. Platform products are primarily used in solutions sold through the CCG, DCG, and IOTG segments
|
PRQ
|
|
Product Release Qualification, which is the milestone when costs to manufacture a product are included in inventory valuation
|
QLC
|
|
Quad-level cell
|
R&D
|
|
Research and development
|
RSU
|
|
Restricted stock unit
|
SEC
|
|
U.S. Securities and Exchange Commission
|
SoC
|
|
System-on-Chip
|
SSD
|
|
Solid-state drive
|
TAM
|
|
Total addressable market
|
TLC
|
|
Triple-level cell
|
U.S. GAAP
|
|
U.S. Generally Accepted Accounting Principles
|
FINANCIAL STATEMENTS
|
Notes to Financial Statements
|
26
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
DCG REVENUE $B
|
|
DCG OPERATING INCOME $B
|
|
■ Platform
|
■ Adjacent
|
REVENUE SUMMARY
|
|
Q1 2020 vs. Q1 2019
|
|||||
(Dollars in Millions)
|
%
|
|
$ Impact
|
|||
|
|
|
|
|
||
Platform volume
|
up
|
27%
|
|
$
|
1,230
|
|
Platform ASP
|
up
|
13%
|
|
715
|
|
|
Adjacent products
|
up
|
35%
|
|
146
|
|
|
|
|
|
|
|
||
Total change in revenue
|
|
|
|
$
|
2,091
|
|
OPERATING INCOME SUMMARY
|
(In Millions)
|
|
|
||
$
|
3,492
|
|
|
Q1 2020 DCG Operating Income
|
1,785
|
|
|
Higher gross margin from platform revenue
|
|
(80
|
)
|
|
Higher operating expenses
|
|
(54
|
)
|
|
Other
|
|
$
|
1,841
|
|
|
Q1 2019 DCG Operating Income
|
MD&A
|
|
27
|
|
INTERNET OF THINGS REVENUE $B
|
|
INTERNET OF THINGS OPERATING INCOME $B
|
|
■ IOTG
|
■ Mobileye
|
|
|
■ IOTG
|
■ Mobileye
|
|
REVENUE AND OPERATING INCOME SUMMARY
|
Q1 2020 vs. Q1 2019
|
MD&A
|
|
28
|
|
NSG REVENUE $B
|
|
NSG OPERATING INCOME $B
|
REVENUE AND OPERATING INCOME SUMMARY
|
Q1 2020 vs. Q1 2019
|
MD&A
|
|
29
|
|
PSG REVENUE $B
|
|
PSG OPERATING INCOME $B
|
REVENUE AND OPERATING INCOME SUMMARY
|
Q1 2020 vs. Q1 2019
|
MD&A
|
|
30
|
|
CCG REVENUE $B
|
|
CCG OPERATING INCOME $B
|
|
■ Platform
|
■ Adjacent
|
REVENUE SUMMARY
|
|
|
Q1 2020 vs. Q1 2019
|
|||||
(Dollars in Millions)
|
|
%
|
|
$ Impact
|
|||
|
|
|
|
|
|
||
Desktop platform volume
|
|
down
|
(4)%
|
|
$
|
(143
|
)
|
Desktop platform ASP
|
|
up
|
4%
|
|
97
|
|
|
Notebook platform volume
|
|
up
|
22%
|
|
1,100
|
|
|
Notebook platform ASP
|
|
down
|
(3)%
|
|
(169
|
)
|
|
Adjacent products and other
|
|
|
|
|
304
|
|
|
|
|
|
|
|
|
||
Total change in revenue
|
|
|
|
|
$
|
1,189
|
|
OPERATING INCOME SUMMARY
|
(In Millions)
|
|
|
||
$
|
4,225
|
|
|
Q1 2020 CCG Operating Income
|
710
|
|
|
Higher gross margin from platform revenue
|
|
700
|
|
|
Lower period charges primarily due to 2019 reserved non-qualified platform product
|
|
305
|
|
|
Lower operating expenses driven by lower investments in modem
|
|
(590
|
)
|
|
Higher platform unit cost due to ramp of 10nm products
|
|
28
|
|
|
Other
|
|
$
|
3,072
|
|
|
Q1 2019 CCG Operating Income
|
MD&A
|
|
31
|
CONSOLIDATED RESULTS OF OPERATIONS
|
|
|
Three Months Ended
|
||||||||||||
|
|
Q1 2020
|
|
Q1 2019
|
||||||||||
(Dollars in Millions, Except Per Share Amounts)
|
|
Amount
|
|
% of Net
Revenue |
|
Amount
|
|
% of Net
Revenue |
||||||
Net revenue
|
|
$
|
19,828
|
|
|
100.0
|
%
|
|
$
|
16,061
|
|
|
100.0
|
%
|
Cost of sales
|
|
7,812
|
|
|
39.4
|
%
|
|
6,972
|
|
|
43.4
|
%
|
||
Gross margin
|
|
12,016
|
|
|
60.6
|
%
|
|
9,089
|
|
|
56.6
|
%
|
||
Research and development
|
|
3,275
|
|
|
16.5
|
%
|
|
3,332
|
|
|
20.7
|
%
|
||
Marketing, general and administrative
|
|
1,541
|
|
|
7.8
|
%
|
|
1,583
|
|
|
9.9
|
%
|
||
Restructuring and other charges
|
|
162
|
|
|
0.8
|
%
|
|
—
|
|
|
—
|
%
|
||
Operating income
|
|
7,038
|
|
|
35.5
|
%
|
|
4,174
|
|
|
26.0
|
%
|
||
Gains (losses) on equity investments, net
|
|
(111
|
)
|
|
(0.6
|
)%
|
|
434
|
|
|
2.7
|
%
|
||
Interest and other, net
|
|
(313
|
)
|
|
(1.6
|
)%
|
|
(61
|
)
|
|
(0.4
|
)%
|
||
Income before taxes
|
|
6,614
|
|
|
33.4
|
%
|
|
4,547
|
|
|
28.3
|
%
|
||
Provision for taxes
|
|
953
|
|
|
4.8
|
%
|
|
573
|
|
|
3.6
|
%
|
||
Net income
|
|
$
|
5,661
|
|
|
28.6
|
%
|
|
$
|
3,974
|
|
|
24.7
|
%
|
|
|
|
|
|
|
|
|
|
||||||
Earnings per share—diluted
|
|
$
|
1.31
|
|
|
|
|
$
|
0.87
|
|
|
|
MD&A
|
|
32
|
|
SEGMENT REVENUE WALK $B
|
GROSS MARGIN $B
|
(In Millions)
|
|
|
||
$
|
12,016
|
|
|
Q1 2020 Gross Margin
|
2,470
|
|
|
Higher gross margin from platform revenue
|
|
770
|
|
|
Lower period charges primarily due to 2019 reserved non-qualified platform product
|
|
335
|
|
|
Higher gross margin from adjacent businesses primarily due to NAND
|
|
(585
|
)
|
|
Higher platform unit cost primarily from increased mix of 10nm and performance products
|
|
(63
|
)
|
|
Other
|
|
$
|
9,089
|
|
|
Q1 2019 Gross Margin
|
|
|
|
MD&A
|
|
33
|
|
RESEARCH AND DEVELOPMENT $B
|
|
MARKETING, GENERAL AND ADMINISTRATIVE $B
|
RESEARCH AND DEVELOPMENT
|
R&D decreased by $57 million, or 1.7%, driven by the following:
|
|
|
|
-
|
Ramp down of 5G smartphone modem business
|
+
|
Investments in our PC and data-centric businesses
|
+
|
Investments in process technology
|
+
|
Profit dependent compensation
|
MARKETING, GENERAL AND ADMINISTRATIVE
|
MG&A decreased by $42 million, or 2.7%, driven by the following:
|
|
|
|
-
|
Corporate spending efficiencies
|
+
|
Profit dependent compensation
|
MD&A
|
|
34
|
(In Millions)
|
|
Q1 2020
|
|
Q1 2019
|
||||
Ongoing mark-to-market adjustments on marketable equity securities
|
|
$
|
(103
|
)
|
|
$
|
253
|
|
Observable price adjustments on non-marketable equity securities
|
|
79
|
|
|
8
|
|
||
Impairment charges
|
|
(143
|
)
|
|
(23
|
)
|
||
Sale of equity investments and other
|
|
56
|
|
|
196
|
|
||
Gains (losses) on equity investments, net
|
|
$
|
(111
|
)
|
|
$
|
434
|
|
|
|
|
|
|
||||
Interest and other, net
|
|
$
|
(313
|
)
|
|
$
|
(61
|
)
|
(Dollars in Millions)
|
|
Q1 2020
|
|
Q1 2019
|
||||
Income before taxes
|
|
$
|
6,614
|
|
|
$
|
4,547
|
|
Provision for taxes
|
|
$
|
953
|
|
|
$
|
573
|
|
Effective tax rate
|
|
14.4
|
%
|
|
12.6
|
%
|
MD&A
|
|
35
|
(Dollars in Millions)
|
|
Mar 28,
2020 |
|
Dec 28,
2019 |
||||
Cash and cash equivalents, short-term investments, and trading assets
|
|
$
|
20,803
|
|
|
$
|
13,123
|
|
Other long-term investments
|
|
$
|
2,943
|
|
|
$
|
3,276
|
|
Loans receivable and other
|
|
$
|
1,294
|
|
|
$
|
1,239
|
|
Reverse repurchase agreements with original maturities greater than three months
|
|
$
|
350
|
|
|
$
|
350
|
|
Total debt
|
|
$
|
39,919
|
|
|
$
|
29,001
|
|
Temporary equity
|
|
$
|
—
|
|
|
$
|
155
|
|
Debt as percentage of permanent stockholders’ equity
|
|
52.3
|
%
|
|
37.4
|
%
|
|
CASH FROM OPERATIONS $B
|
|
CAPITAL EXPENDITURES $B
|
|
CASH TO STOCKHOLDERS $B
|
|
|
|
|
■ Dividends ■ Buybacks
|
|
|
Three Months Ended
|
||||||
(In Millions)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Net cash provided by operating activities
|
|
$
|
6,158
|
|
|
$
|
4,959
|
|
Net cash used for investing activities
|
|
(3,736
|
)
|
|
(2,722
|
)
|
||
Net cash provided by (used for) financing activities
|
|
4,764
|
|
|
(2,102
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
|
$
|
7,186
|
|
|
$
|
135
|
|
MD&A
|
|
36
|
MD&A
|
|
37
|
Non-GAAP adjustment or measure
|
Definition
|
Usefulness to management and investors
|
Acquisition-related adjustments
|
Amortization of acquisition-related intangible assets consists of amortization of intangible assets such as developed technology, brands, and customer relationships acquired in connection with business combinations. Charges related to the amortization of these intangibles are recorded within both cost of sales and MG&A in our U.S. GAAP financial statements. Amortization charges are recorded over the estimated useful life of the related acquired intangible asset, and thus are generally recorded over multiple years.
|
We exclude amortization charges for our acquisition-related intangible assets for purposes of calculating certain non-GAAP measures because these charges are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. These adjustments facilitate a useful evaluation of our current operating performance and comparison to our past operating performance and provide investors with additional means to evaluate cost and expense trends.
|
Restructuring and other charges
|
Restructuring charges are costs associated with a formal restructuring plan and are primarily related to employee severance and benefit arrangements. Other charges include asset impairments, pension charges, and costs associated with restructuring activity.
|
We exclude restructuring and other charges, including any adjustments to charges recorded in prior periods, for purposes of calculating certain non-GAAP measures because these costs do not reflect our current operating performance and are significantly impacted by the timing of restructuring activity. These adjustments facilitate a useful evaluation of our current operating performance and comparisons to past operating results and provide investors with additional means to evaluate expense trends.
|
Ongoing mark-to-market on marketable equity securities
|
After the initial mark-to-market adjustment is recorded upon a security becoming marketable, gains and losses are recognized from ongoing mark-to-market adjustments of our marketable equity securities.
|
We exclude these ongoing gains and losses for purposes of calculating certain non-GAAP measures because we do not believe this volatility correlates to our core operational performance. These adjustments facilitate a useful evaluation of our current operating performance and comparisons to past operating results.
|
Free cash flow
|
We reference a non-GAAP financial measure of free cash flow, which is used by management when assessing our sources of liquidity, capital resources, and quality of earnings. Free cash flow is operating cash flow adjusted to exclude additions to property, plant, and equipment.
|
This non-GAAP financial measure is helpful in understanding our capital requirements and provides an additional means to evaluate the cash flow trends of our business.
|
MD&A
|
|
38
|
|
|
Three Months Ended
|
||||||
(In Millions, Except Per Share Amounts)
|
|
Mar 28,
2020 |
|
Mar 30,
2019 |
||||
Operating income
|
|
$
|
7,038
|
|
|
$
|
4,174
|
|
Acquisition-related adjustments
|
|
339
|
|
|
331
|
|
||
Restructuring and other charges
|
|
162
|
|
|
—
|
|
||
Non-GAAP operating income
|
|
$
|
7,539
|
|
|
$
|
4,505
|
|
|
|
|
|
|
||||
Operating margin
|
|
35.5
|
%
|
|
26.0
|
%
|
||
Acquisition-related adjustments
|
|
1.7
|
%
|
|
2.1
|
%
|
||
Restructuring and other charges
|
|
0.8
|
%
|
|
—
|
%
|
||
Non-GAAP operating margin
|
|
38.0
|
%
|
|
28.0
|
%
|
||
|
|
|
|
|
||||
Earnings per share—diluted
|
|
$
|
1.31
|
|
|
$
|
0.87
|
|
Acquisition-related adjustments
|
|
0.08
|
|
|
0.07
|
|
||
Restructuring and other charges
|
|
0.04
|
|
|
—
|
|
||
Ongoing mark-to-market on marketable equity securities
|
|
0.03
|
|
|
(0.05
|
)
|
||
Income tax effect
|
|
(0.01
|
)
|
|
—
|
|
||
Non-GAAP earnings per share—diluted
|
|
$
|
1.45
|
|
|
$
|
0.89
|
|
|
|
|
|
|
||||
Net cash provided by operating activities
|
|
$
|
6,158
|
|
|
$
|
4,959
|
|
Additions to property, plant and equipment
|
|
(3,268
|
)
|
|
(3,321
|
)
|
||
Free cash flow
|
|
$
|
2,890
|
|
|
$
|
1,638
|
|
|
|
|
|
|
||||
Net cash used for investing activities
|
|
$
|
(3,736
|
)
|
|
$
|
(2,722
|
)
|
Net cash provided by (used for) financing activities
|
|
$
|
4,764
|
|
|
$
|
(2,102
|
)
|
MD&A
|
|
39
|
OTHER KEY INFORMATION
|
OTHER KEY INFORMATION
|
|
40
|
•
|
geopolitical and security issues, such as armed conflict and civil or military unrest, political instability, human rights concerns, and terrorist activity, including, for example, geopolitical tensions and conflict affecting Israel, where our Mobileye business headquarters and certain of our fabrication facilities are located;
|
•
|
natural disasters, public health issues (including the COVID-19 pandemic discussed further in the risk factor “The COVID-19 pandemic could materially adversely affect our financial condition and results of operations,” above), and other catastrophic events;
|
•
|
inefficient infrastructure and other disruptions, such as supply chain interruptions and large-scale outages or unreliable provision of services from utilities, transportation, data hosting, or telecommunications providers;
|
•
|
formal or informal imposition of new or revised export, import, or doing-business regulations, including trade sanctions, tariffs, and changes in the ability to obtain export licenses, which could be changed without notice;
|
•
|
government restrictions on, or nationalization of, our operations in any country, or restrictions on our ability to repatriate earnings from a particular country;
|
•
|
adverse changes relating to government grants, tax credits, or other government incentives;
|
•
|
differing employment practices and labor issues;
|
•
|
ineffective legal protection of our IP rights in certain countries;
|
OTHER KEY INFORMATION
|
|
41
|
•
|
local business and cultural factors that differ from our current standards and practices;
|
•
|
continuing uncertainty regarding social, political, immigration, and tax and trade policies in the U.S. and abroad, including as a result of the United Kingdom's withdrawal from the European Union;
|
•
|
fluctuations in the market values of our domestic and international investments, which can be negatively affected by liquidity, credit deterioration or losses, interest rate changes, financial results, political risk, sovereign risk, or other factors; and
|
•
|
uncertainty regarding LIBOR—certain of our interest rate derivatives and investments are based on LIBOR, and a portion of our indebtedness bears interest at variable interest rates, primarily based on LIBOR: LIBOR is the subject of recent national, international and other regulatory guidance and proposals for reform, which may cause LIBOR to disappear entirely after 2021 or to perform differently than in the past, and while we expect that reasonable alternatives to LIBOR will be implemented prior to the 2021 target date, we cannot predict the consequences and timing of these developments, and they could include an increase in our interest expense and/or a reduction in our interest income.
|
OTHER KEY INFORMATION
|
|
42
|
Period
|
|
Total Number
of Shares Purchased (In Millions) |
|
Average Price
Paid Per Share |
|
Dollar Value of
Shares That May Yet Be Purchased Under the Program (In Millions) |
|||||
December 29, 2019 - January 25, 2020
|
|
17.9
|
|
|
$
|
60.39
|
|
|
$
|
22,687
|
|
January 26, 2020 - February 22, 2020
|
|
17.2
|
|
|
$
|
66.27
|
|
|
$
|
21,547
|
|
February 23, 2020 - March 28, 2020
|
|
36.2
|
|
|
$
|
52.11
|
|
|
$
|
19,658
|
|
Total
|
|
71.3
|
|
|
|
|
|
OTHER KEY INFORMATION
|
|
43
|
|
|
|
|
Incorporated by Reference
|
|
|
||||||
Exhibit
Number
|
|
Exhibit Description
|
|
Form
|
|
File Number
|
|
Exhibit
|
|
Filing
Date
|
|
Filed or
Furnished
Herewith
|
3.1
|
|
|
8-K
|
|
000-06217
|
|
3.1
|
|
5/22/2006
|
|
|
|
3.2
|
|
|
8-K
|
|
000-06217
|
|
3.2
|
|
1/17/2019
|
|
|
|
4.1
|
|
|
8-K
|
|
000-06217
|
|
4.1
|
|
2/13/2020
|
|
|
|
4.2
|
|
|
8-K
|
|
000-06217
|
|
4.2
|
|
2/13/2020
|
|
|
|
4.3
|
|
|
8-K
|
|
000-06217
|
|
4.1
|
|
3/25/2020
|
|
|
|
10.1†
|
|
|
|
|
|
|
|
|
|
|
X
|
|
10.2†
|
|
|
8-K
|
|
000-06217
|
|
10.1
|
|
1/22/2020
|
|
|
|
10.3†
|
|
|
|
|
|
|
|
|
|
|
X
|
|
31.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
32.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
101.INS
|
|
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
|
|
|
|
|
|
|
|
X
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
104
|
|
Cover Page Interactive Data File - formatted in Inline XBRL and included as Exhibit 101
|
|
|
|
|
|
|
|
|
|
X
|
OTHER KEY INFORMATION
|
|
44
|
Item Number
|
Item
|
|
Part I - Financial Information
|
|
|
Item 1.
|
Financial Statements
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations:
|
|
|
Results of operations
|
|
|
Liquidity and capital resources
|
|
|
Off-balance sheet arrangements
|
(a)
|
|
Contractual obligations
|
Page 37
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
Page 37
|
Item 4.
|
Controls and Procedures
|
Page 43
|
|
|
|
Part II - Other Information
|
|
|
Item 1.
|
Legal Proceedings
|
|
Item 1A.
|
Risk Factors
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
Page 43
|
Item 3.
|
Defaults Upon Senior Securities
|
Not applicable
|
Item 4.
|
Mine Safety Disclosures
|
Not applicable
|
Item 5.
|
Other Information
|
Not applicable
|
Item 6.
|
Exhibits
|
|
|
|
|
Signatures
|
|
Page 46
|
(a)
|
As of March 28, 2020, we did not have any significant off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.
|
OTHER KEY INFORMATION
|
|
45
|
|
|
|
INTEL CORPORATION
(Registrant) |
||
|
|
|
|
|
|
Date:
|
April 23, 2020
|
|
By:
|
|
/s/ GEORGE S. DAVIS
|
|
|
|
|
|
George S. Davis
|
|
|
|
|
|
Executive Vice President, Chief Financial Officer and Principal Financial Officer
|
|
|
|
|
|
|
Date:
|
April 23, 2020
|
|
By:
|
|
/s/ KEVIN T. MCBRIDE
|
|
|
|
|
|
Kevin T. McBride
|
|
|
|
|
|
Vice President of Finance, Corporate Controller and Principal Accounting Officer
|
|
|
46
|
i.
|
“Intel TSR” is a percentage (to the third decimal point) derived by:
|
(1)
|
A numerator that is the difference of the average closing sale price of Common Stock during the 3 months prior to and including the last day of the Performance Period (the “INTC Ending Average Price”) minus the average closing sale price of Common Stock during the 3 months following and including the first day of the Performance Period (the “INTC Beginning Average Price”).
|
(2)
|
A denominator that is the INTC Beginning Average Price.
|
(3)
|
The percentage will be adjusted to reflect that any dividends paid or payable with respect to an ex-dividend date that occurs during the Performance Period shall be treated as though they had been reinvested in the Common Stock as of such ex-dividend date based on the closing sale price of Common Stock on such date.
|
(4)
|
Any dividend paid in securities with a readily ascertainable fair market value will be valued at the market value of the securities as of the ex-dividend date. Any dividend paid in other property will be valued based on the value assigned to such dividend by the paying company for tax purposes.
|
(5)
|
The Compensation Committee may adjust Intel TSR for equity restructuring transactions including, but not limited to, a stock split, combination of shares, extraordinary dividend of cash and/or assets, recapitalization or reorganization.
|
ii.
|
“S&P 500 IT TSR” is a percentage (to the third decimal point) derived by:
|
(1)
|
A numerator that is the difference of the average closing sale price of the total return index for the Standard & Poor’s 500 Information Technology Index during the 3 months prior to and including the last day of the Performance Period (the “S&P Ending Average Price”) minus the average closing sale price of the total return index for the Standard & Poor’s 500 Information Technology Index (which measure assumes reinvestment of dividends paid on the Standard & Poor’s 500 Information Technology Index) during the 3 months following and including the first day of the Performance Period (the “S&P Beginning Average Price”).
|
(2)
|
A denominator that is S&P Beginning Average Price.
|
(3)
|
The total return index for the Standard & Poor’s 500 Information Technology Index shall be as reported by S&P Capital IQ (or such other reporting service as the Committee may designate from time to time). For the avoidance of doubt, the companies included in the Standard & Poor’s 500 Information Technology Index during the S&P Beginning Average Price period may be different from the companies included in the index during the S&P Ending Average Price period as a result of changes in the composition of the index made by Standard & Poor’s (or its successor).
|
i.
|
The “EPS Growth Payout” will be determined in accordance with following:
|
(1)
|
If EPS Growth Percentage is equal to the EPS Growth Target (as set forth in your Notice of Grant), the EPS Growth Payout is 100%.
|
(2)
|
If EPS Growth Percentage is greater than the EPS Growth Target, the EPS Growth Payout is 100% plus: the difference of the EPS Growth Percentage minus the EPS Growth Target, times the fraction of 100/4.5 (i.e., (EPS Growth Percentage – EPS Growth Target) * 100/4.5).
|
(3)
|
If EPS Growth Percentage is less than the EPS Growth Target), the EPS Growth Payout is 100% plus: the difference of the EPS Growth minus the EPS Growth Target, times the fraction of 100/9.1 (i.e., (EPS Growth Percentage – EPS Growth Target) * 100/9.1).
|
ii.
|
EPS Growth Percentage is the percentage (to the third decimal point) derived from the following, minus 100:
|
(1)
|
A numerator that is the sum of the annual Non-GAAP earnings per share (“Non-GAAP EPS”) amounts of each of the three fiscal years of the Corporation of the Performance Period.
|
(2)
|
A denominator that is the sum of the annual Non-GAAP EPS amounts of the fiscal year of the Corporation immediately before the Performance Period and the first and second fiscal years of the Corporation of the Performance Period.
|
(3)
|
The Compensation Committee may adjust the final EPS Growth Payout to eliminate the impact of certain unbudgeted, unusual, or infrequent events or occurrences during the Performance Period, as specified by the Compensation Committee in its sole discretion.
|
A.
|
NON-U.S. PROVISIONS
|
(2)
|
The 2006 Plan and your participation in it are offered by the Corporation on a wholly discretionary basis;
|
(4)
|
None of the Corporation, the Employer or any Subsidiary is responsible for any decrease in the value of any shares of Common Stock acquired at vesting of the RSUs.
|
(2)
|
El 2006 Plan y su participación en el 2006 Plan se ofrecen por la Compañía de manera totalmente discrecional;
|
(4)
|
Ninguna de las empresas subsidiarias de la Compañía ni su Patrón son responsables de ninguna disminución en el valor de las Acciones adquiridas al momento de tener el derecho respecto a las Unidades de Acciones Restringidas.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Intel Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
April 23, 2020
|
|
By:
|
/s/ ROBERT H. SWAN
|
|
|
|
|
Robert H. Swan
|
|
|
|
|
Chief Executive Officer, Director and Principal Executive Officer
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Intel Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
April 23, 2020
|
|
By:
|
/s/ GEORGE S. DAVIS
|
|
|
|
|
George S. Davis
|
|
|
|
|
Executive Vice President, Chief Financial Officer and Principal Financial Officer
|
Date:
|
April 23, 2020
|
|
By:
|
/s/ ROBERT H. SWAN
|
|
|
|
|
Robert H. Swan
|
|
|
|
|
Chief Executive Officer, Director and Principal Executive Officer
|
|
|
|
|
|
Date:
|
April 23, 2020
|
|
By:
|
/s/ GEORGE S. DAVIS
|
|
|
|
|
George S. Davis
|
|
|
|
|
Executive Vice President, Chief Financial Officer and Principal Financial Officer
|